The CFM recommends that Anvisa ban PMMA in aesthetic procedures, warning of serious health complications.
The Federal Council of Medicine (CFM) recommended to Anvisa that the use of polymethylmethacrylate (PMMA) in aesthetic procedures be prohibited. The entity also called for the suspension of the manufacture and sale of fillers that contain this substance in Brazil. The CFM warned that PMMA can cause serious complications, including infections and inflammatory reactions, and can even lead to death, as pointed out by organizations such as the Brazilian Society of Plastic Surgery. PMMA is a plastic material that has several applications, one of which is filling the skin. However, the number of reports of complications arising from the use of this product in aesthetic procedures has increased in the country. Currently, Anvisa allows the use of PMMA only in reparative treatments, and its application must be carried out exclusively by qualified professionals.
In addition to concerns about PMMA, a study carried out by CFM indicated that many aesthetics courses do not require medical training for their students. This situation generates concern regarding patient safety, especially when invasive procedures are performed by people without proper training. The CFM reinforced the urgency of implementing measures that ensure compliance with Brazilian legislation related to the practice of medicine. Given this scenario, the CFM highlights the importance of stricter regulations for the practice of aesthetic procedures, aiming to protect the health of the population. The entity believes that the lack of adequate supervision can result in significant risks for patients, and that it is essential that only trained professionals carry out interventions that involve the use of substances such as PMMA.
Published by Sarah Paula
*Report produced with the help of AI
